Venture capital firms Forbion Capital Partners, which spun out from Dutch bank ABN Amro at the end of 2006, and Edmond de Rothschild Investment Partners have co-led a series A financing round in newly-launched Allecra Therapeutics. The €15m ($20m) commitment will support early clinical development of two new antibiotic treatments designed to combat multi drug-resistant…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.